Equities

Entrada Therapeutics Inc

TRDA:NMQ

Entrada Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)15.00
  • Today's Change1.35 / 9.89%
  • Shares traded138.03k
  • 1 Year change+4.31%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Entrada Therapeutics Inc increased its cash reserves by 45.71%, or 22.45m. The company earned 139.80m from its operations for a Cash Flow Margin of 108.36%. In addition the company generated 21.04m cash from financing while 138.40m was spent on investing.
Cash flow per share3.12
Price/Cash flow per share4.71
Book value per share11.57
Tangible book value per share11.57
More ▼

Balance sheet in USDView more

Entrada Therapeutics Inc uses little or no debt in its capital structure.
Current ratio5.70
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.